IMN || Cardiology

Too much dietary sugar raises CVD mortality

Posted on: 03/02/2014 - 21:00

Excess intake of sugar in the diet significantly raises the risk of cardiovascular mortality, independently of other risk factors, according to an analysis of National Health and Nutrition...

Field of Interest: Cardiology
Type: News Item

FDA investigating testosterone’s cardiovascular risks

Posted on: 03/02/2014 - 14:00

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Cardiology
Type: News Item

FDA investigating testosterone’s cardiovascular risks

Posted on: 03/02/2014 - 14:00

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Geriatrics
Type: News Item

WOEST results guide antithrombotic therapy in PCI

Posted on: 30/01/2014 - 13:55

SNOWMASS, COLO. – A recent randomized trial provides physicians with important new guidance on how to manage antithrombotic therapy in patients requiring oral anticoagulation who develop an acute...

Field of Interest: Cardiology
Type: News Item

CoreValve holds size advantage for U.S. TAVR

Posted on: 28/01/2014 - 21:10

When the Food and Drug Administration in January granted marketing approval to a second transcatheter aortic valve replacement system for inoperable patients with aortic stenosis, the CoreValve...

Field of Interest: Cardiology
Type: News Item

Former JNC 8 hypertension panel issues minority report

Posted on: 28/01/2014 - 17:15

The controversial hypertension-management guidelines released by the former JNC 8 panel in December was not the group’s last word. There was a minority report, too, published almost a month later in...

Field of Interest: Geriatrics
Type: News Item

FDA approves dapagliflozin for type 2 diabetes

Posted on: 08/01/2014 - 20:20

Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes with a requirement that the manufacturer conduct postmarketing studies that address...

Field of Interest: Endocrinology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness